InsidersTradesSigma
申报总数
公司
▲ 买入（0 笔）
▼ 卖出（4 笔）
内部人交易记录
董事已披露买入
0
已披露卖出
4
尚无足够的、已确定 T+90 期限的买入信号来衡量交易记录。
信号历史
Discover the complete record of transactions filed by Mitchell Stephen Ray, 董事. Officer active across 1 company, notably Vanda Pharmaceuticals Inc.. Cumulatively, 11 disclosures have been published. Breakdown: 0 buy · 4 sells. Total volume traded: €113k. History available since 10 June 2021. The latest transaction was filed on 13 June 2025 (Cession). Regulator: SEC (Form 4). The full history is accessible without signup.
Companies and markets linked to Mitchell Stephen Ray
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
申报11 总计
7,000 股@ US$4.5913.8% 占其流量Common StockSEC:0000950170-25-087025:0
59,225 股0Common StockSEC:0000950170-25-083890:0
5,000 股@ US$5.17269.3% 占其流量Common StockSEC:0000950170-24-128115:0
20,529 股0Common StockSEC:0000950170-24-063017:0
6,500 股@ US$6.053713.7% 占其流量Common StockSEC:0001209191-23-045447:0
17,307 股0Common StockSEC:0001209191-23-036285:0
12,006 股0Common StockSEC:0001209191-22-038448:0
2,700 股@ US$9.47890.0065% mcap12.2% 占其流量Common StockSEC:0001209191-22-036835:0
5,985 股@ US$10.5726.6% 占其流量Common StockSEC:0001209191-21-055685:0
4,015 股@ US$10.5717.4% 占其流量Common StockSEC:0001209191-21-041496:0
5,000 股0Common StockSEC:0001209191-21-040240:0
11 条申报中的 11 条
About Mitchell Stephen Ray
Mitchell Stephen Ray is a Director at Vanda Pharmaceuticals Inc. (XNAS). He has 11 filings in total, and across the sampled recent filings between 2021-06-14 and 2025-06-16, sells total EUR 112584 and the most frequent transaction nature is Attribution.
